DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Platzbecker U. et al.
Luspatercept for the Treatment of Anaemia in Patients With Lower-Risk Myelodysplastic Syndromes (PACE-MDS): A Multicentre, Open-Label Phase 2 Dose-Finding Study With Long-Term Extension Study.
Lancet Oncol 2017;
18: 1338-1347
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.